pharmaphorum
DECEMBER 4, 2017
Change Together – www.changetogether.com – will be presenting a live webinar with leading figures from the patient advocacy community, who will debate how we can drive positive change for patients through collaboration and education. This will be helpful for all advocates, as we hear and learn from our expert panel how their organizations are bringing about change.
The Digital Apothecary
AUGUST 15, 2017
Ever since Christina Farr of CNBC broke the news of Amazon expressing an interest of getting into the Billion Dollar Pharmacy market, I have been having multiple conversations with many people inside and outside of pharmacy on how this will change "everything." Personally, I haven't seen this much attention in awhile about pharmacy since PillPack made strip-packaging of medications mainstream three-years ago, and am quite eager to see if this is really going to change the current paradigm of pha
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Board Vitals - Pharmacist
JUNE 14, 2017
Preparing for the ABIM Cardiovascular Disease Board Exam is no easy feat. Have a go at 6 cardiology board exam sample questions that will definitely test your knowledge and see if you’re as prepared as you think you are for the cardiology boards. Good luck! We hope you performed well. Whether you did better than you thought you would or you didn’t live up to your standards, we’re here to help you improve.
Med Ed 101
DECEMBER 31, 2017
In the video below, I lay out some information regarding preparation for the BCPS Pharmacotherapy Exam. It is a very challenging exam with approximately 1/3 failing the exam. I outline some ideas on how to prepare, what the exam looks like, and the importance of reviewing the content outline. BCPS study material from Meded101.com has […]. The post BCPS Pharmacotherapy Exam Study Strategies – How to Prepare appeared first on Med Ed 101.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
NOVEMBER 28, 2017
Networks of influence are shifting the decision-making process for life sciences companies. It is no longer enough to simply view the profile of a HCP or HCO to understand their value to your organization. For life sciences organizations, there is currently a gap in information, understanding, and digital access to these critical customer networks and relationships.
pharmaphorum
NOVEMBER 23, 2017
Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights? As shown in the consumer world, social media can be a very rich source of insights into customers and markets, and can provide early signals of new trends. Exactly the same is true for patient and health care provider insights, especially when used with other more traditional data sets.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
NOVEMBER 6, 2017
The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system. In summer 2016 the Cancer Vanguard medicines optimisation team launched the ‘Pharma Challenge’ as an opportunity for the pharma and life sciences indust
pharmaphorum
SEPTEMBER 6, 2017
Across Europe, a shift towards greater prevention, earlier diagnosis and treatment is needed in order to contain the growing cost of healthcare. But how can healthcare systems make this transition – and how do pharmaceutical companies play a role in this, while also growing their market? A forthcoming webinar hosted by pharmaphorum with sponsor PHOENIX group looks at how harnessing the data and expertise of pharmacies, and via greater engagement with patients, consumers and shoppers can meet thi
The Digital Apothecary
JUNE 30, 2017
So, you're a pharmacist or another healthcare professional looking to update or create some standout portfolio/resume. It's tough, isn't it? I mean, look online for ideas and you will quickly get inundated with so many design ideas. My experience is some of those out there are very design heavy (hence their creation by artists and designers to showcase their work) or just look so normal.
pharmaphorum
JUNE 29, 2017
With a wealth of market and regulatory changes impacting the medtech sector, it’s time for digital technology to steer the direction of your future business. This expert webinar will evaluate how to strategically embed digital within your own organisation and explore the challenges and the opportunities for transforming customer relationships, driving commercial outcomes.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JUNE 20, 2017
A digital debate analysing the future for biologics in the UK and the factor affecting market access in this territory. Our expert panel will cover a number of key topics including: •Are the savings offered by biosimilars being used to innovate and take advantage of the exciting new biologic technologies or just filling in the NHS potholes? •Will the industry continue to invest in cutting-edge research if the UK is not prepared to fund access to it •In a post-Brexit world how can the UK continue
pharmaphorum
JUNE 12, 2017
Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans. Biopharma companies must take into account a multitude of factors when considering physician prescribing behaviors, and need a more integrated "pull-through" strategy across their teams, from managed markets, to marketing, to field sales.
The Digital Apothecary
MAY 13, 2017
History Still Matters. It's just how we use it. Medical education offers a snapshot of current practices and literature for many students under the guidance of current practitioners. Educators across all healthcare spheres rely on teaching what the current standards of care and evaluation in the medical environment at present are to help them get them to their clinical experiences prepared.
pharmaphorum
MAY 3, 2017
Growing patient influence combined with new technologies and the requirements of new reimbursement models means clinical research is undergoing rapid transformation. Industry is being compelled to move towards more patient centric solutions to keep up with these changes. With healthcare stakeholders in agreement that patient engagement is key to realising the value of clinical trials, regulators, sponsors, CROs, research funders and publishers are all moving towards more patient-focused models.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
APRIL 27, 2017
The life sciences landscape is moving at a rapid pace, which in turn is increasing the demands on marketers to create innovative, digital content faster while maintaining industry compliance. Veeva Systems recently conducted an annual industry study, focused on content and digital asset management within life sciences. Gleaned from the experiences and opinions of leaders across the life sciences industry, the research uncovers current practices and the industry’s need for more advanced approache
The Digital Apothecary
APRIL 11, 2017
When I was a student in pharmacy school, one of our earliest assignments was the so-called 'JellyBean Experiment,' whereby students were assigned a longitudinal project in which they were to mimic a patient with a chronic condition treated with medications. The assignment is aimed to help students understand the pill burden that patients face on a daily basis, and in my mind, bring in a better empathetic understanding towards nonadherence and how to talk about it.
pharmaphorum
APRIL 10, 2017
Over the past few years there has been a shift in the European pharmaceutical market landscape, with a rise in specialty medicines for diseases with narrow patient populations. Indeed, QuintilesIMS forecasts that, between 2013 and 2018, 94% of list price value growth will be in specialty medicines – with orphan drugs at the forefront of this trend. On 10 April 2017, QuintilesIMS, in partnership with pharmaphorum presents a unique digital debate, bringing together a panel of senior industry exper
pharmaphorum
MARCH 29, 2017
Pharmacists are highly trained healthcare professionals who have a deep understanding of medicines and daily contact with patients and consumers. This puts them in a unique position in terms of being able to maximise the benefits that patients get from their medicines – however, healthcare systems and pharmaceutical companies frequently overlook this potential.
pharmaphorum
MARCH 10, 2017
2017 is once again a year of significant change for pharma market access in Europe, with affordability on the agenda for almost every country in the region. There is a move toward greater collaboration in health technology assessment and more transparency between countries for pricing, therapeutic protocols and and details of negotiations with drug manufacturers.
Med Ed 101
DECEMBER 27, 2017
Alex Barker, PharmD is on a mission to help pharmacists create inspiring work and lives. He is the creator “The Happy PharmD” He put together this guest post cover letters for your residency application. Pharmacy school doesn’t leave you with much energy for anything else. You invest thousands of dollars and thousands of hours just trying to survive. […].
Med Ed 101
DECEMBER 24, 2017
There is always a huge challenge in navigating CHF and CKD in our patients. Use of diuretics and ACE inhibitors can be life altering in a very good way for patients who have fluid overload. The difficulty lies in keeping an adequate perfusion to the kidney. A 69 year old male presents to the emergency […]. The post Navigating CHF and CKD appeared first on Med Ed 101.
Med Ed 101
DECEMBER 20, 2017
The allopurinol and cyclosporine interaction is one that isn’t as common as other interactions. One of the major reasons is that cyclosporine is a medication that is generally used for a very specialized purpose. Cyclosporine is a calcineurin inhibitor that is primarily used in organ transplantation. A 58 year old male is receiving chronic cyclosporine […].
Med Ed 101
DECEMBER 17, 2017
Here’s a case scenario of a potential case of ACE inhibitor induced psoriasis. If you are looking for more info on the ACE Inhibitors, be sure to check out the podcast! Mrs AX, 70 years old, never smoked, BMI 27 kg/m2, presents with new onset of itchy scalp. Her regular medicines include omeprazole 20mg, rosuvastatin […]. The post ACE Inhibitor Induced Psoriasis appeared first on Med Ed 101.
Med Ed 101
DECEMBER 13, 2017
There’s been a recent change in the hypertension guidelines. Recommendations from AHA/ACC have been made to get a little more aggressive with hypertension management compared to JNC-8. I outline some of the important differences in the presentation below. I have also added this to the 20+ hour BCPS pharmacotherapy webinar. I’m giving year long access for […].
Med Ed 101
DECEMBER 10, 2017
There are a lot of examples that fit this criteria and I suspect a lot of heavy opinions on this topic. I’ve certainly made suggestions to switch to a likely “safer” medication, but have had instances where I disagree with this practice as well in our elderly patient population. Is age a reason to change […]. The post Is Age a Reason to Change a Medication appeared first on Med Ed 101.
Med Ed 101
DECEMBER 6, 2017
I will be heading on my way back to Minnesota tomorrow, so this will be the last ASHP Midyear post. Hope you all enjoyed it, and maybe I will head back next year…we’ll see! Day 4 of ASHP Midyear took on a medication safety theme. I took part in a pain management in opioid use […]. The post ASHP Midyear 2017 Day 4 appeared first on Med Ed 101.
Med Ed 101
DECEMBER 5, 2017
I’m a little late on my day 2 wrap up of the ASHP Midyear meeting. With ongoing discussions today with more pharmacists, residents and students, I can’t help but think what pharmacy is going to look like in 10 or 20 years. I think the key to identifying what’s going to happen is to think […]. The post ASHP Midyear Day 2 2017 appeared first on Med Ed 101.
Med Ed 101
DECEMBER 5, 2017
Day 3 at ASHP 2017 has been a little more depressing due to the pharmacist job market. I’ve been speaking to quite a few residents and students, and I seem to leave those conversations with pessimism. The pharmacist job market feels bad. Many students, residents, and young pharmacists from across the country are feeling the […]. The post Pharmacist Job Market Outlook – ASHP Midyear 2017 Day 3 (Tuesday) appeared first on Med Ed 101.
Med Ed 101
DECEMBER 3, 2017
For those of you looking for BCPS help in the next year or two, you better not wait any longer – This one time only initial offer will end Monday December 4th, 2017! On Day 1 of ASHP Midyear, I had a really enjoyable day of interacting with some fantastic pharmacists as well as learning […]. The post Day 1 – ASHP Midyear Meeting 2017 appeared first on Med Ed 101.
Med Ed 101
NOVEMBER 26, 2017
Here’s a case scenario with a primary focus on the NSAID prescribing cascade. A 76 year old male has a past medical history of: COPD CHF Hypertension GERD Osteoarthritis Current medications include: Metoprolol 25 mg BID Lisinopril 10 mg daily Symbicort 160/4.5 two puffs BID Qvar 40 mcg one inhalation twice daily Albuterol 1-2 puffs […]. The post NSAID Prescribing Cascade appeared first on Med Ed 101.
Med Ed 101
NOVEMBER 22, 2017
Consultant pharmacists play a very important role in long term care. We often support nursing and providers in assurance that medications are used appropriate and safely in our residents. Antibiotic stewardship in long term care is an ever expanding topic and agencies are placing a larger role on consultant pharmacists to do more. The question […].
Med Ed 101
NOVEMBER 19, 2017
There are lots of different medications utilized in type 2 diabetes. Finding that perfect combination can be a challenge, and what has worked for them in the past may not always necessarily work in the future as things change. Here I demonstrate the importance of looking back as to why a patient isn’t on a […]. The post Add On Diabetes Therapy to Insulin appeared first on Med Ed 101.
Med Ed 101
NOVEMBER 15, 2017
Our BCPS All Access Pass is now available! You can find it here under the BCPS tab. For now, here’s a free sample of one of the over 100+ videos! The post Free SAMPLE! Pharmacotherapy Prep Course from Meded101 appeared first on Med Ed 101.
Med Ed 101
NOVEMBER 12, 2017
Using glyburide in kidney disease is not recommended. It has a longer half life and may have a little more potent effect in kidney disease. A significant challenge to figure out is if patients are doing well on their current dose, should we change it? In this scenario, patient changes give us the opportunity to […]. The post Glyburide in Kidney Disease appeared first on Med Ed 101.
Expert insights. Personalized for you.
52 
Let's personalize your content